Report Highlights
The global market for industrial enzymes was valued at $3.1 billion in 2009 and reached about $3.6 billion in 2010. The estimated market for 2011 is about $3.9 billion. BCC projects this market to grow at a compounded annual growth rate (CAGR) of 9.1% to reach $6 billion by 2016.
Report Scope
The scope of this study encompasses the industrial enzymes, bio-technical, chemical and biotechnology markets. BCC analyzes each market and its applications, regulatory environment, technology involved, market projections and market share. Technological issues include the latest trends and developments.
Analyst Credentials
Shalini Shahani Dewan focuses on pharmaceuticals and biotechnology and has been a BCC Research contributor since 2002 as both an analyst and project manager. She has explored a wide range of topics and companies, including working for Johnson & Johnson doing market surveillance. She has an undergraduate degree in pharmacy and master's degree in medicinal chemistry. She resides in the Bay Area.
Report Highlights
The global market for industrial enzymes is estimated at $3.3 billion in 2010. This market is expected to reach $4.4 billion by 2015, a compound annual growth rate (CAGR) of 6% over the 5-year forecast period.
Report Highlights
This Report:
- The global market for industrial enzymes increased from $2.2 billion in 2006 to an estimated $2.3 billion by the end of 2007. It should reach $2.7 billion by 2012, a compound annual growth rate (CAGR) of 4%.
- The greatest growth rate is expected in the animal enzymes sector, with a CAGR of 6% between 2007 and 2012, helped in large part by the increased use of phytase enzymes to fight phosphate pollution.
- New and emerging applications have helped drive demand for enzymes, and the industry is responding with a continuous stream of innovative products.
Report Highlights
-
The global market for industrial enzymes is estimated at $2 billion in 2004 and is expected to rise at an average annual growth rate (AAGR) of 3.3% to $2.4 billion in 2009.
-
Volume growth of industrial enzymes is between a 4% and 5% AAGR, and is accompanied by decreasing prices.
-
Growth of the animal feed enzyme sector is somewhat higher, at nearly a 4% AAGR, helped by increased use of phytase enzyme to fight phosphate pollution.
-
Technical enzymes for detergent and pulp and paper manufacturing, among others, are the largest segment with a 52% share. Growth will parallel the overall market.
Report Highlights
-
Total U.S. consumption of enzymes is estimated at $514 million in 2000.
-
Growing at an average annual rate (AAGR) of 4.1%, usage will reach $629.3 million by 2005.
-
Pulp and paper applications will show the most growth, at an AAGR of 6.5% through the period.
-
Detergent/cleaners are second, with 5% annually on average. Food and animal feed applications dominate the current market, accounting for just under half the total value.
Related Reports
Enzymes in Industrial Applications: Global Markets
The global market for industrial enzymes is estimated at $3.3 billion in 2010. This market is expected to reach $4.4 billion by 2015, a compound annual growth rate (CAGR) of 6% over the 5-year forecast period.
Recent Reports
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.
High Content Screening/Imaging: Technologies and Global Markets
The global market for high content screening and imaging (HCS/I) is estimated to increase from $3.4 billion in 2024 to reach $5.1 billion by 2029, at a compound annual growth rate (CAGR) of 8.4% from 2024 through 2029.
Biomarkers: Technologies and Global Markets
The global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Alzheimer's Disease Therapeutics and Diagnostics: Global Markets
The global market for Alzheimer’s disease therapeutics and diagnostics was valued at $9 billion in 2023. This market is expected to grow from $9.7 billion in 2024 to $19.6 billion by 2029, at a compound annual growth rate (CAGR) of 15.1% from 2024 to 2029.
In Vitro Diagnostics: Technologies and Global Markets
The global market for In Vitro Diagnostics (IVD) is expected to grow from $94.7 billion in 2024 and is projected to reach $141.9 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.4% during the forecast period of 2024 to 2029.
OTC Drugs, Medical Devices and Diagnostics: Global Markets
The global market for OTC drugs, medical devices, and diagnostics is estimated to increase from $251.7 billion in 2024 to reach $359.7 billion by 2029, at a compound annual growth rate (CAGR) of 7.4% from 2024 through 2029.
Biomarkers: Technologies and Global Markets
The global market for biomarkers was valued at $63.7 billion in 2023. This market is expected to grow from $70.5 billion in 2024 to $130.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 13.1% from 2024 through 2029.
Liquid Biopsy Research Tools, Services and Diagnostics: Global Markets
The global market for liquid biopsy is expected to grow from $4.6 billion in 2024 and is projected to reach $13.1 billion by the end of 2029, at a compound annual growth rate (CAGR) of 23.3% during the forecast period of 2024 to 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More